Boston-area startups and tech firms raised nearly $3.2B in November, according to data compiled by BostInno.
In the life sciences hub of Boston, biotech nearly always dominates funding, and last month was no exception. Biotech firms — several of them newly launched — collectively brought in more than $2.4B, or more than three-quarters of all funding raised in the region.
That category, in turn, was fueled mostly by two massive raises. Ginkgo Bioworks secured a loan of up to $1.1B from the U.S. International Development Finance Corporation to expand its biosecurity efforts, including its response to the Covid-19 pandemic on both the testing and vaccine fronts. Exactly one week prior to that, Resilience, a new company headquartered in Boston and San Diego that aims to build “the world's most advanced biopharmaceutical manufacturing ecosystem,” launched with over $800M in capital.
One venture capital fund and one special-purpose acquisition company, which are listed below but which we did not include in the total, also raised a collective $524.6 million.
FYI, we cover startup funding news in the BostInno Beat newsletter every weekday. Stay on top of who’s getting funded by signing up right here. See you in the inbox.
Below are the startups and related firms that raised capital in November, according to our research.
Biotech
Erbi Biosystems, a Woburn-based microfluidic bioprocess instrumentation company based on technology developed at MIT, disclosed that it raised $3.8M in a funding round led by Jaguar Biotech.
Boston-based microbiome startup DermBiont raised $7.2M in equity in an $8M funding round, per an SEC filing.
Dewpoint Therapeutics, a Boston-based molecular condensates company, raised $77.1M in equity, according to an SEC filing.
Cambridge-based biotech DoubleRainbow Biosciences raised $10M in equity in a $20M funding round, per an SEC filing.
Decibel Therapeutics, a clinical-stage biotech using gene therapy to treat hearing loss and balance disorders, closed an oversubscribed Series D round at $82.2M. The financing was led by OrbiMed, with new investments from BlackRock Health Sciences, Casdin Capital, Janus Henderson, Samsara BioCapital and Surveyor Capital.
Kytopen, a Cambridge startup working on gene-modified cell therapies, raised $3.1M in equity in a $4M funding round, per an SEC filing.
Waltham-based Adagio Therapeutics, which is developing antibodies that broadly neutralize SARS-CoV-2, SARS-CoV-1 and potentially other coronaviruses, closed an $80M Series B funding round. The round was led by GV with participation from existing investors Polaris Partners, Mithril Capital, Fidelity Management & Research Company and OrbiMed, as well as new investors Population Health Partners and Omega Funds.
Cambridge-based Apic Bio, which is developing cures for patients with genetic diseases, raised $12.1M in equity in a $46.1M funding round, per an SEC filing.
X-COR Therapeutics, an Allston-based developer of a novel extracorporeal carbon dioxide removal device, closed a $2.6M seed round. Alira Health Ventures led, with syndication from Good Growth Capital, PiSA Biopharm, Flybridge Partners’ Graduate Syndicate and other notable angel investors.
Nereid Therapeutics launched with a $50M investment from Apple Tree Partners to expand on Clifford Brangwynne’s research. The Princeton University professor has spent more than a decade exploring cellular function and biomolecular condensates — the droplets within cells that can impact the ways in which genes are read and turned on or off.
Manus Bio, a Cambridge-based producer of complex natural products through advanced fermentation, raised $75M in Series B financing. The round was led by BBGI Public Company Limited, a manufacturer and distributor of bio-based products in Bangkok, Thailand.
Satellite Biosciences, a Cambridge startup pioneering the development and implementation of proprietary, off-the-shelf, implantable satellite organs as living therapeutic solutions, raised $19M in equity, per an SEC filing.
Boston-based ImmunoMolecular Therapeutics, a clinical-stage company developing personalized therapies for autoimmune disease, raised $7M in equity in a $10M funding round, per an SEC filing.
Cambridge biotech Aulos Bioscience raised $15M in equity in a $40M funding round, per an SEC filing.
Woburn-based microbiome startup MarvelBiome raised $3.1M in equity in a $20M funding round, per an SEC filing.
Cambridge-based Particles for Humanity, a biotech company transforming early-stage technologies into products for people in low-resource settings, received a $5M grant from the Bill & Melinda Gates Foundation to evaluate a single-injection vaccine delivery technology developed at MIT.
Resilience, a new company headquartered in Boston and San Diego that aims to build “the world's most advanced biopharmaceutical manufacturing ecosystem,” launched with over $800M of capital led by ARCH Venture Partners and 8VC, with participation by GV, NEA, public mutual funds, pharmaceutical companies, foundations, family offices and pension funds. Resilience will focus on manufacturing cell and gene therapies, viral vectors, vaccines and proteins.
Catamaran Bio, a Cambridge-based biotech developing allogeneic CAR-NK cell therapies to treat cancer, launched with $42M in Series A financing. The round was co-led by Sofinnova Partners and Lightstone Ventures, with participation from founding investor SV Health Investors, as well as Takeda Ventures and Astellas Venture Management.
Boston-based anti-aging startup Elevian closed a $15M round led by Prime Movers Lab with participation from Bold Capital Partners, For Good Ventures, Kizoo Ventures, Lauder Partners, Longevity Fund, SavEarth Fund, WTI and several prominent angels.
Ginkgo Bioworks secured a loan of up to $1.1B from the U.S. International Development Finance Corporation to expand its biosecurity efforts, including optimizing the manufacturing of Covid-19 vaccines, delivering widespread testing and building the infrastructure needed to help identify, prevent and respond to future pandemics.
Cleantech & Greentech
Form Energy, the Somerville startup planning to make battery systems that can efficiently store wind and solar energy for long periods of time, closed a Series C round of more than $70M, Reuters reported.
SparkCharge, a Somerville-based maker of a portable electric vehicle charger that appeared on "Shark Tank" this fall, raised $1M in equity in a $3M funding round, per an SEC filing.
Boston Meats, a Harvard spinout now housed at Greentown Labs that is developing lab-grown meat, raised $1.3M in equity, per an SEC filing.
Funds & SPACs
E14, the MIT Media Lab-affiliated venture fund, has raised approximately $24.6M in pooled investment fund interests as part of a prospective $80M total, according to an SEC filing unearthed by the Boston Business Journal.
Health Assurance Acquisition, the new SPAC formed by General Catalyst, met its fundraising goal of $500M, Fortune reported.
Health Tech
Buoy Health, a Boston-based, AI-powered health care navigation platform, raised $37.5M in Series C funding, bringing the round to $66.5M to date. The round was led by Cigna Ventures and Humana with participation from Optum Ventures, WR Hambrecht + Co and Trustbridge Partners.
Figur8, a Boston startup behind wearable fitness sensors, raised $6.2M in equity in an $8M funding round, per an SEC filing. ICYMI, check out the sensors in action from Sri's BostInno Tries last November.
Outcomes4Me, Cambridge-based developer of a free mobile app and platform to navigate cancer treatment and care, raised $4.7M in funding led by Asset Management Ventures with participation from Sierra Ventures, Merstal Ltd. and others. A portion of the funding includes federal funds from the National Cancer Institute.
Medtech
Cambridge-based Dynocardia, a startup creating wearables for continuous, non-invasive blood pressure monitoring, raised $1.5M in debt, per new SEC filings.
Neuroelectrics, a Spanish company with local headquarters in Cambridge that produces devices to stimulate and treat the brain, raised $17.9M in equity, per an SEC filing.
Cambridge-based Photomedics, maker of a light device that eliminates potentially pathogenic bacteria in the mouth, raised $2.3M in equity, per an SEC filing.
Robotics & Hardware
Pickle Robot, an MIT spinoff that launched last May, raised $2M in equity, per an SEC filing.
Cambridge-based Suvie, officially Home Tech Innovation, a startup behind a robotic cook-and-refrigerate kitchen appliance, raised $8.1M in equity in an $11.6M funding round, per an SEC filing.
Services
Arlington-based mobile mechanic Zippity raised $1.9M in equity in a $2M funding round, per an SEC filing.
Software
Cambridge-based GivingData, a software company that provides a platform for grant writers, raised $3M in equity, per an SEC filing.
Boston-based insurtech company REIN Technologies raised $1.9M in debt in a $5M funding round, per an SEC filing.
Mable, a mobile and web-based B2B wholesale platform based in Newburyport, raised $8.5M in equity, per an SEC filing.
Reprise emerged from stealth with a $3.2M seed round co-led by Glasswing Ventures and Accomplice Ventures. The company has developed a platform for sales and marketing teams to build demos.Boston-based online auto loan provider Lendbuzz raised $23.6M in equity, per an SEC filing.
Boston-based Aryeo, a content management platform for the real estate industry, raised $3.6M in equity and intends to raise another $25K, per an SEC filing.
DataRobot, the Boston-based enterprise AI company that hit unicorn status last September after a $207M Series E round, brought in another massive fundraise: $270M in what the startup called a "pre-IPO round" led by Altimeter Capital. Other participating investors included T. Rowe Price, Blackrock, Silverlake, NEA and Tiger.
Boston-based Klaviyo, a customer data and marketing platform for online businesses, raised $200M in Series C funding, led by Accel with participation from existing investor Summit Partners.
Zapata Computing, a Cambridge-based quantum computing startup that spun out of Harvard in 2017, raised $38M in Series B funding to optimize workflows, particularly for large enterprises. The round was co-led by Comcast Ventures, Pitango and Prelude Ventures, with participation from BASF Venture Capital, Robert Bosch Venture Capital, The Engine Accelerator Fund, Ahren Innovation Capital, Alumni Ventures Group, Honeywell Venture Capital, ITOCHU Corporation and Merck Global Health Innovation Fund.
Boston-based call analytics startup Cogito closed a $25M convertible debt round led by Goldman Sachs Growth Equity, Salesforce Ventures and others. The funding will be used to expand its go-to-market efforts and accelerate the development of new products.
Somerville-based real estate software startup RentalBeast raised $2M in convertible notes, per an SEC filing.
Givinga, a Boston-based startup behind a platform for corporate philanthropy, raised $2.4M in equity in a $4.4M funding round, per an SEC filing.
Logz.io, the Boston- and Israel-based startup behind a software analytics platform for DevOps teams, pulled in $23M to accelerate its go-to-market strategy. The round was led by Pitango Growth and included participation from existing investors.
Marlborough-based insurtech company OneShield Software announced a growth investment of an undisclosed amount from a private investor group led by Bain Capital Credit, LP and Pacific Lake Partners.
